SARS-CoV-2 infection is associated with hypothalamic orexin suppression and persistent cortical NeuN attenuation.

Saved in:
Bibliographic Details
Title: SARS-CoV-2 infection is associated with hypothalamic orexin suppression and persistent cortical NeuN attenuation.
Authors: Yoon GY; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea., Chung YC; Division of Advanced Predictive Research, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.; Human and Environmental Toxicology, University of Science and Technology (UST), Daejeon, 34114, Republic of Korea., Choi JH; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea., Ha Y; Department of Bioinformatics & Life Science, Soongsil University, Seoul, 06978, Republic of Korea., Seo SY; Department of Bioinformatics & Life Science, Soongsil University, Seoul, 06978, Republic of Korea., Ku KB; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea., Kim DY; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.; College of Pharmacy, Korea University, Sejong, 30019, Republic of Korea., Hwang WY; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.; College of Pharmacy, Korea University, Sejong, 30019, Republic of Korea., Jeong GU; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea.; Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea., Ahn DG; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea., Kim KD; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea., Rhee JK; Department of Bioinformatics & Life Science, Soongsil University, Seoul, 06978, Republic of Korea.; AI-Bio Convergence Research Institute, Soongsil University, Seoul, 06978, Republic of Korea., Shin WH; Division of Advanced Predictive Research, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea. whshin@kitox.re.kr.; Human and Environmental Toxicology, University of Science and Technology (UST), Daejeon, 34114, Republic of Korea. whshin@kitox.re.kr., Kwon YC; Center for Infectious Diseases Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, 34114, Republic of Korea. yckwon@krict.re.kr.; Medical Chemistry and Pharmacology, University of Science and Technology (UST), Daejeon, 34114, Republic of Korea. yckwon@krict.re.kr.
Source: Journal of neuroinflammation [J Neuroinflammation] 2026 May 05. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1742-2094
DOI:10.1186/s12974-026-03842-y